Jiabin Jin

1.5k total citations · 1 hit paper
50 papers, 1.0k citations indexed

About

Jiabin Jin is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiabin Jin has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 26 papers in Surgery and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiabin Jin's work include Pancreatic and Hepatic Oncology Research (38 papers), Renal cell carcinoma treatment (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Jiabin Jin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (38 papers), Renal cell carcinoma treatment (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Jiabin Jin collaborates with scholars based in China, United Kingdom and Sri Lanka. Jiabin Jin's co-authors include Baiyong Shen, Chenghong Peng, Xiaxing Deng, Hao Chen, Qian Zhan, Yusheng Shi, Yuanchi Weng, Zhen Huo, Shulin Zhao and Jian Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cancer Cell.

In The Last Decade

Jiabin Jin

48 papers receiving 987 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer

2024 91 citations Ningning Niu, Xuqing Shen et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiabin Jin China	17	714	464	407	221	202	50	1.0k
Gregory Sergeant Belgium	17	599 0.8×	586 1.3×	256 0.6×	187 0.8×	106 0.5×	36	1.1k
Hongbeom Kim South Korea	19	906 1.3×	717 1.5×	507 1.2×	171 0.8×	86 0.4×	118	1.2k
Takanobu Yamao Japan	15	548 0.8×	377 0.8×	303 0.7×	120 0.5×	88 0.4×	55	840
Nevra Dursun Türkiye	15	534 0.7×	507 1.1×	271 0.7×	88 0.4×	101 0.5×	43	935
Matteo Palmeri Italy	17	582 0.8×	559 1.2×	401 1.0×	117 0.5×	147 0.7×	70	1.1k
Paulus Schurr Germany	13	387 0.5×	325 0.7×	268 0.7×	139 0.6×	165 0.8×	28	807
Soichi Murakami Japan	18	903 1.3×	528 1.1×	359 0.9×	121 0.5×	173 0.9×	80	1.3k
Natsuko Kawada Japan	19	454 0.6×	653 1.4×	498 1.2×	69 0.3×	76 0.4×	43	1.3k
Ulrich Stölzel Germany	17	339 0.5×	116 0.3×	175 0.4×	120 0.5×	226 1.1×	32	793
Hideki Kamada Japan	17	522 0.7×	471 1.0×	378 0.9×	139 0.6×	172 0.9×	56	815

Countries citing papers authored by Jiabin Jin

Since Specialization

Citations

This map shows the geographic impact of Jiabin Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabin Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabin Jin more than expected).

Fields of papers citing papers by Jiabin Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiabin Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabin Jin. The network helps show where Jiabin Jin may publish in the future.

Co-authorship network of co-authors of Jiabin Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiabin Jin. A scholar is included among the top collaborators of Jiabin Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiabin Jin. Jiabin Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Guosen, Yi Cao, Zhihong Cai, et al.. (2025). A Mutual Interaction Between GSTP1 and p53 Improves the Drug Resistance and Malignant Biology of Pancreatic Cancer. Cancer Science. 116(5). 1268–1281. 1 indexed citations

2.

Jiang, Yu, Shiwei Zhao, Dongyu Liu, et al.. (2024). Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns. Cell Communication and Signaling. 22(1). 164–164. 1 indexed citations

3.

Niu, Ningning, Xuqing Shen, Yueyue Chen, et al.. (2024). Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 42(5). 869–884.e9. 91 indexed citations breakdown →

4.

Zhou, Yiran, Jiabin Jin, Jun Wang, et al.. (2023). TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma. Journal of Translational Medicine. 21(1). 872–872. 4 indexed citations

5.

Jin, Jiabin, et al.. (2022). Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing. Cancer Medicine. 11(18). 3397–3406. 3 indexed citations

6.

Jin, Jiabin, Yina Jiang, Yinying Wu, et al.. (2022). Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas. Frontiers in Oncology. 12. 927107–927107. 11 indexed citations

7.

Chen, Yuyang, et al.. (2021). A Variable Curvature Model for Multi-Backbone Continuum Robots to Account for Inter-Segment Coupling and External Disturbance. IEEE Robotics and Automation Letters. 6(2). 1590–1597. 40 indexed citations

8.

Shi, Yusheng, Xinjing Wang, Junjie Xie, et al.. (2021). Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer. Frontiers in Oncology. 10. 611809–611809. 3 indexed citations

9.

Wen, Chenlei, Xiaxing Deng, Song Xue, et al.. (2020). Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma. Cancer Medicine. 9(20). 7626–7636. 2 indexed citations

10.

Gu, Jiangning, Zhiwei Xu, Yang Ma, et al.. (2020). Surgical resection of metastatic pancreatic cancer: is it worth it?—a 15-year experience at a single Chinese center. Journal of Gastrointestinal Oncology. 11(2). 319–328. 8 indexed citations

11.

Weng, Yuanchi, Georgios Gemenetzis, Yusheng Shi, et al.. (2020). Robotic-assisted versus open total pancreatectomy: a propensity score-matched study. HepatoBiliary Surgery and Nutrition. 9(6). 759–770. 13 indexed citations

12.

Wang, Yue, Jingfeng Li, Yuanchi Weng, et al.. (2019). A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy. Translational Cancer Research. 8(7). 2613–2620. 3 indexed citations

13.

Wang, Yue, Jingfeng Li, Yuanchi Weng, et al.. (2019). A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy. Translational Cancer Research. 8(7). 2613–2620. 6 indexed citations

14.

Shi, Yusheng, Jiabin Jin, Zhen Huo, et al.. (2019). An 8-year single-center study: 170 cases of middle pancreatectomy, including 110 cases of robot-assisted middle pancreatectomy. Surgery. 167(2). 436–441. 12 indexed citations

15.

Jin, Jiabin, Yi Yang, Yusheng Shi, et al.. (2019). Robotic pancreatectomy for solid pseudopapillary tumors in the pancreatic head: A propensity score-matched comparison and analysis from a single center. Asian Journal of Surgery. 43(1). 354–361. 17 indexed citations

16.

Ma, Yang, Yiran Zhou, Xiayang Ying, et al.. (2019). Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China. International Journal of Clinical Oncology. 24(6). 686–693. 12 indexed citations

17.

Chen, Shi, Qian Zhan, Jiabin Jin, et al.. (2016). Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial. Surgical Endoscopy. 31(2). 962–971. 38 indexed citations

18.

Chen, Shi, Qian Zhan, Jiang-Zhi Chen, et al.. (2015). Robotic approach improves spleen-preserving rate and shortens postoperative hospital stay of laparoscopic distal pancreatectomy: a matched cohort study. Surgical Endoscopy. 29(12). 3507–3518. 91 indexed citations

19.

Jiang, Yu, Jiabin Jin, Qian Zhan, Xiaxing Deng, & Baiyong Shen. (2015). Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors. Chinese Medical Journal. 128(24). 3335–3344. 36 indexed citations

20.

Lu, Xiongxiong, Jiaxin Hu, Yan Fang, et al.. (2014). A case-control study indicates that the TRIB1 gene is associated with pancreatic cancer. Genetics and Molecular Research. 13(3). 6142–6147. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact